Company:  ALLARITY THERAPEUTICS, IN ... (ALLR)
Form Type:  424B3
Filing Date:  6/7/2022 
CIK:  0001860657 
Address:  210 BROADWAY
SUITE 201
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  401-426-4664 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.14  
Change: 
-0.01 (-0.87%)  
Trade Time: 
Sep 23  
Market Cap: 
$11.34M
Trade ALLR now with

© 2022  
Description of Business
We are a clinical stage biopharmaceutical company targeting some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates together with our proprietary DRP® companion diagnostics in a precision medicine approach. Our business strategy includes a focus on leveraging our proprietary DRP® companion diagnostics platform to streamline the drug development process and to identify patients that will benefit from therapeutic candidates that other biotechnology or pharmaceutical companies have abandoned or shelved after initiating clinical trials under an IND application filed with the FDA, including candidates that have failed to achieve statistical significance on the original endpoints established in their clinical trials.
Register and access this filing in:     
  FORM 424B3
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    Recent Recapitalization Share Exchange, Asset Acquisition ...
    Recent Business Development
    Summary of Risk Factors
    The Offering
    RISK FACTORS
    General Risk Factors
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    MARKET INFORMATION FOR OUR SECURITIES AND DIVIDEND POLICY
    Dividend Policy
    SELECTED HISTORICAL FINANCIAL INFORMATION
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
      Components of Operating Expenses
      Competition
      Legal Proceedings
    MANAGEMENT
      NAME AND TITLE
    Executive Compensation and Director Compensation
      COMPENSATION TABLE
    Non-Employee Director Compensation
      NAME AND TITLE
    CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
    Transactions with Related Parties
    Related Person Transactions Policy
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
    SELLING STOCKHOLDER
      BENEFICIAL OWNERS
    PLAN OF DISTRIBUTION
    DESCRIPTION OF OUR CAPITAL STOCK
    EXPERTS
    LEGAL MATTERS
    WHERE YOU CAN FIND ADDITIONAL INFORMATION
    INDEX TO FINANCIAL STATEMENTS
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
      Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        CASH FLOW
      NOTES TO FINANCIAL STATEMENTS
        BALANCE SHEET
        STOCKHOLDERS EQUITY
      OPTIONS